| Metric | შპს ნიუ ფარმა | შპს ჯორჯიან ფარმაცევტიკალსი |
|---|---|---|
| Growth | ||
| Revenue | ₾14.6m₾21.9m | ₾7.9m₾6.6m |
| Revenue growth | -33.2% | 18.9% |
| Profitability | ||
| EBITDA | -₾27k₾3.5m | ₾2.8m₾1.9m |
| EBITDA margin | -0.2%15.8% | 35.4%29.4% |
| Net profit | -₾1.2m₾2.1m | ₾2.6m₾1.4m |
| Net margin | -8.4%9.7% | 33.6%20.8% |
| Balance sheet | ||
| Total assets | ₾9.7m₾10.9m | ₾7.9m₾5.6m |
| Total equity | ₾3.4m₾5.9m | ₾7.9m₾5.1m |
| ROE | -35.4%36.1% | 33.5%27.0% |